Ann: AGM Presentation, page-68

TBH either could surprise the market .... MSB could finally pull off a CHF partnership deal or IMU could see a takeover proposal or lucrative license deal, which would send either company's share prices in those circumstances on an upwards trajectory ..... either way, the bottom line is that both companies need to demonstrate efficacy beyond reproach of BP interference if they are to succeed in the USA (IMO of course)

I am enthused by IMU's results to date but that said I am also encouraged by MSB CHF results ..... who get's there first is anybody's guess really given both companies have open dialogue with the FDA on a number of indications .... GLTAH